US-based healthcare diagnostic company Alzeca Biosciences Inc has secured $11m through a series A venture financing round.

The company plans to use the funds towards the development of its ADx nanoparticle.

UK-based point-of-care company Sphere Medical Holding Plc plans to raise a total of £8m ($9.84m) through two private placements of 283 million convertible preferred shares priced at £0.03 ($0.04) each.

"The company plans to use the funds towards the development of its ADx nanoparticle."

Senseonics Holdings Inc has announced a public offering of 11 million common stock shares priced at $2.15 each to raise $25.02m.

The US-based company plans to use the funds towards the commercialisation of its glucose monitoring system named Eversense and for general corporate purposes.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.